MedTrace Logo

Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis

NCT01466634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6221

Last updated 2011-11-08

No results posted yet for this study

Summary

Evidence supporting use of bioabsorbable polymer drug eluting stents (BP-DES) is uncertain. Thus the investigators planned a meta-analysis to compare outcomes of BP-DES versus PP-DES in obstructive coronary artery disease.

Conditions

Interventions

PROCEDURE

percutaneous coronary intervention with stent

patients with coronary artery disease treated by percutaneous coronary intervention with BP-DES are compared with patients with coronary artery disease treated by percutaneous coronary intervention with PP-DES

Sponsors & Collaborators

  • Azienda Ospedaliero Universitaria Maggiore della Carita

    lead OTHER

Principal Investigators

  • Alessandro Lupi, MD · AOU Maggiore della Carita

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-09-30
Completion
2011-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466634 on ClinicalTrials.gov